227 related articles for article (PubMed ID: 25048529)
21. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
22. Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease.
Foreman PM; Jackson BE; Singh KP; Romeo AK; Guthrie BL; Fisher WS; Riley KO; Markert JM; Willey CD; Bredel M; Fiveash JB
J Clin Neurosci; 2018 Mar; 49():48-55. PubMed ID: 29248376
[TBL] [Abstract][Full Text] [Related]
23. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
Yomo S; Hayashi M
J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
[TBL] [Abstract][Full Text] [Related]
24. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
25. Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.
Nguyen TK; Sahgal A; Detsky J; Atenafu EG; Myrehaug S; Tseng CL; Husain Z; Heyn C; Maralani P; Ruschin M; Perry J; Soliman H
Neuro Oncol; 2020 Jan; 22(1):84-93. PubMed ID: 31412120
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
[TBL] [Abstract][Full Text] [Related]
28. Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery.
Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
Neurooncol Adv; 2021; 3(1):vdab036. PubMed ID: 33860228
[TBL] [Abstract][Full Text] [Related]
29. From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
Udovicich C; Ng SP; Tange D; Bailey N; Haghighi N
Oper Neurosurg (Hagerstown); 2022 Apr; 22(4):208-214. PubMed ID: 35234410
[TBL] [Abstract][Full Text] [Related]
30. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
32. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
33. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
34. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
35. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
[TBL] [Abstract][Full Text] [Related]
36. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
[TBL] [Abstract][Full Text] [Related]
38. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
[TBL] [Abstract][Full Text] [Related]
39. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
